Voloridge Investment Management
GHDX

Voloridge Investment Management’s Genomic Health, Inc. GHDX Stock Holding History

Voloridge Investment Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-10,848
Closed -$736K – 1472
2019
Q3 		$736K Sell
10,848
-7,653
-41% -$526K 0.01% 713
2019
Q2 		$1.08M Sell
18,501
-102
-0.5% -$6.04K 0.03% 444
2019
Q1 		$1.3M Buy
+18,603
New +$1.38M 0.04% 396

Voloridge Investment Management's GHDX Position: Q4 2019 in Review

Voloridge Investment Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 10,848 shares — an estimated $736K sold.

Voloridge Investment Management first reported a position in GHDX in Q1 2019 and held it in 3 quarters. The position peaked at $1.3M in Q1 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

  • Voloridge Investment Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
  • Voloridge Investment Management sold 10,848 Genomic Health, Inc. shares in Q4 2019, an estimated $736K.
  • Voloridge Investment Management first reported a position in Genomic Health, Inc. in Q1 2019 and held it in 3 quarters.
  • Voloridge Investment Management's Genomic Health, Inc. position peaked at $1.3M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Voloridge Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.